Akouos, Inc.

Regeneron Pharmaceuticals, Inc. 's acquisition of Decibel Therapeutics, Inc. last year is looking like a very smart move after the gene therapy at the heart of the deal restored hearing to normal le

The relentless expansion of Pharma’s R&D pipeline was checked somewhat last year, even as the proportion of drugs in active development for cancer reached new heights, and the burgeoning industry in A

Biopharma Acquisitions Biopharma merger and acquisition value for the fourth quarter of 2022 reached $35.7bn from 41 transactions, 21 of which had disclosed values. Making up 78% of the Q4 total was A

As 2022 draws to a close, an unusually low number of marquee deals have been made in the biopharma sector. But it has been a hectic year nonetheless, with a high volume of deal-making and the lower va